ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $644,000 | +11.4% | 48,468 | +30.6% | 1.37% | +1283.8% |
| Q4 2018 | $578,000 | +18.4% | 37,111 | +49.3% | 0.10% | +98.0% |
| Q3 2018 | $488,000 | -26.6% | 24,849 | +7.2% | 0.05% | -91.5% |
| Q2 2018 | $665,000 | -35.6% | 23,175 | -46.9% | 0.59% | -34.3% |
| Q1 2018 | $1,032,000 | +4.1% | 43,653 | -5.5% | 0.90% | -28.1% |
| Q4 2017 | $991,000 | -30.2% | 46,214 | -23.0% | 1.24% | +551.3% |
| Q3 2017 | $1,419,000 | +20.1% | 60,003 | 0.0% | 0.19% | +8.5% |
| Q2 2017 | $1,182,000 | +12.6% | 60,003 | +20.0% | 0.18% | -5.9% |
| Q1 2017 | $1,050,000 | +23.5% | 50,019 | +10.6% | 0.19% | -26.4% |
| Q4 2016 | $850,000 | +68.3% | 45,209 | +87.0% | 0.25% | +4.1% |
| Q3 2016 | $505,000 | -6.3% | 24,177 | +14.4% | 0.24% | -39.0% |
| Q2 2016 | $539,000 | +32.1% | 21,130 | +37.1% | 0.40% | -28.8% |
| Q1 2016 | $408,000 | – | 15,412 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 428,000 | $8,046,000 | 1.90% |
| SCOPIA CAPITAL MANAGEMENT LP | 4,532,067 | $85,203,000 | 1.61% |
| DLD Asset Management, LP | 247,300 | $4,656,000 | 1.52% |
| Broadfin Capital, LLC | 644,153 | $12,110,000 | 1.34% |
| Perceptive Advisors | 720,000 | $13,536,000 | 0.96% |
| DLD Asset Management, LP | 135,493 | $2,547,000 | 0.83% |
| Malaga Cove Capital, LLC | 51,013 | $971,000 | 0.64% |
| Baker Brothers Advisors | 3,301,791 | $62,074,000 | 0.61% |
| Worth Venture Partners, LLC | 29,300 | $551,000 | 0.59% |
| Spark Investment Management LLC | 327,900 | $6,164,000 | 0.51% |